|4Jan 30, 9:04 AM ET

Chacko David M. 4

4 · Erasca, Inc. · Filed Jan 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Erasca CFO/CBO David Chacko Receives 640,000-Share Award

What Happened
David M. Chacko, Erasca’s Chief Financial Officer and Chief Business Officer, received a large equity award and also purchased shares through the company ESPP. On 2026-01-29 he was granted a 640,000-share derivative award (reported at $0.00), and on 2025-12-15 he purchased 17,793 shares under the company’s 2021 Employee Stock Purchase Plan at $1.19 per share for about $21,250. The ESPP purchase is an outright employee share purchase (a purchase), while the 640,000-share item is a derivative grant subject to vesting — not an immediate open-market sale.

Key Details

  • Transaction dates and prices:
    • 2025-12-15: ESPP purchase of 17,793 shares at $1.19 each; total ≈ $21,250. (Footnotes F1, F2)
    • 2026-01-29: Grant/award of 640,000 derivative shares reported at $0.00 (no immediate cash price shown). (Footnote F3)
  • Vesting/terms: Footnote F3 states 1/48th of the shares subject to the option vest monthly on the 29th (or last Feb day), starting Feb 2026, conditioned on continuous service — indicating a 48‑month monthly vesting schedule.
  • Shares owned after transaction: Not provided in the excerpt supplied.
  • Filing timeliness: The Form 4 was filed 2026-01-30. The 2025-12-15 ESPP purchase was reported late (filed well after the typical 2-business-day window); the 2026-01-29 grant was reported the next day and appears timely.
  • Footnotes:
    • F1: ESPP purchase.
    • F2: Purchase price calculated under the 2021 ESPP.
    • F3: Monthly 1/48th vesting beginning Feb 2026, subject to continued service.

Context
The ESPP purchase is a straightforward buy of company stock by an executive (often seen as a modestly bullish/aligning action). The 640,000-share item is a derivative equity grant (likely options or restricted stock units with a multi-year vesting schedule) and does not reflect an immediate cash transaction or sale of shares. Derivative grants like this are common for executive compensation and are subject to vesting conditions; they don’t indicate immediate liquidating activity.

Insider Transaction Report

Form 4
Period: 2025-12-15
Chacko David M.
CFO and CBO
Transactions
  • Other

    Common Stock

    [F1][F2]
    2025-12-15$1.19/sh+17,793$21,250279,980 total
  • Award

    Stock option (right to buy)

    [F3]
    2026-01-29+640,000640,000 total
    Exercise: $10.31Exp: 2036-01-29Common Stock (640,000 underlying)
Footnotes (3)
  • [F1]Shares purchased under the Company's 2021 Employee Stock Purchase Plan
  • [F2]The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan.
  • [F3]1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date.
Signature
/s/ Ebun Garner, Attorney-in-fact|2026-01-30

Documents

1 file
  • 4
    ownership.xmlPrimary

    4